Lingang's Grant-to-Equity Model Heats Up: A New Funding Path for Early-Stage Hard Tech
On September 21, 2026, the Lingang New Area Administrative Committee released an update on its "grant-to-equity" mechanism. The third batch of 2026 saw 37 projects present at a roadshow spanning AI, cell and gene therapy, embodied intelligence, integrated circuits, and high-end and energy equipment. Applications reached 80, nearly triple the previous batch. This surge reflects a fundamental shift in how public funds support early-stage hard tech.
From Ex-Ante Subsidy to Grant-to-Equity: The Changing Role of Fiscal Capital
Unlike traditional ex-ante subsidies that focus on what a company currently has, the grant-to-equity model cares about what it might become. According to Wang Fengzhuang, an official from the Lingang New Area Administrative Committee's High-Tech Division, the mechanism imposes no hard requirements on operating profit or co-investment capacity. Instead, it prioritizes original technology routes, team execution, and market potential. Fiscal funds are first injected as project grants; after the company completes its first market-based financing or M&A, the funds convert to equity at market valuation. The conversion point is placed after social capital enters, providing a market reference for fairer pricing.
This design directly addresses a core pain point: seed-stage and early-stage hard tech companies often have clear technology directions but lack collateralizable assets. Traditional credit and equity financing struggle to cover them. Lingang's solution lets fiscal funds absorb early risk through grants, then convert to equity after market validation—lowering the early financing threshold while preserving a share of upside for public capital.
Who Is Applying? Project Sources Widen Significantly
Among the 36 cumulative approved projects, high-end equipment leads with 9, followed by integrated circuits (8), embodied intelligence (6), AI (4), smart vehicles (3), low-altitude economy (2), biomedicine (2), nuclear fusion (1), and new materials (1). This structure clearly maps to Lingang's priority industrial tracks.
More notable is the broadening source of projects. In addition to existing university partners such as Shanghai Jiao Tong University, Fudan University, and Peking University, the latest batch added 16 universities including Xidian University, Tianjin University, and Shanghai University, plus three research institutes including the Chinese Academy of Sciences' Institute of Semiconductors and Hefei Institutes of Physical Science. Executives and core R&D staff from chain-leading companies such as Huawei, Horizon, and CATL, as well as overseas giants like NVIDIA and Toshiba, also applied. By source, university professor teams account for 15, industry chain leaders and leading enterprises 10, research institute fellows 8, and returnee talent 3.
Expert review focuses on three dimensions: technological advancement, industrialization feasibility, and Lingang compatibility. The format combines project presentation, Q&A, and expert opinions. This is not just a screening mechanism but an empowerment process—helping teams clarify technology iteration, IP layout, mass production paths, and financing pace, pushing "good technology" toward "landable, scalable, and investable."
A Real Case: Qicaiwei's Leap from 0 to 1
At the end of 2024, Li Weimin founded Qicaiwei (Shanghai) Electronic Materials Co., Ltd., specializing in photoresist resins—often called the "blood" of chip manufacturing. Funding shortages became the first hurdle. In 2025, Qicaiwei was selected for Lingang's first grant-to-equity batch, received 5 million yuan in special support, completed a 15 million yuan first-round equity investment, and achieved conversion. In April 2026, its Lingang laboratory opened, equipped with an R&D line with annual capacity exceeding 300 kg, capable of delivering samples up to 3 kg per batch with total metal impurities below 100 ppb.
Li said the government stepped in at the toughest moment, helping stabilize R&D rhythm. This case reveals the deeper value of grant-to-equity: it is not just a funding tool but a signaling mechanism—fiscal entry provides credit endorsement for subsequent market financing, while deferred conversion avoids premature founder dilution.
Operationally, the model features rolling applications and batch selection. Once approved, funds are disbursed in stages aligned with R&D progress, accompanied by equal amounts of unsecured credit lines. To date, Lingang has completed three batches in 2025 and two in 2026, approving 36 projects with over 400 million yuan in new investment and 115 million yuan in special support funds.
Implications for Private Enterprises Entering Early-Stage Hard Tech
The core value of Lingang's grant-to-equity model lies in using fiscal funds to absorb early-stage risk, converting to equity at market valuation to share growth returns, and providing credit endorsement for subsequent social capital. For private enterprises, this means a more complete support system for entering early-stage hard tech—technical teams can focus on R&D, industrial capital can follow on, and chain leaders can open scenarios. The key questions are whether the company has an original technology route, genuine commercialization intent, and willingness to make Lingang its first choice for landing.
Source: Lingang New Area Administrative Committee official website (lingang.gov.cn)